Advances in Brief Hypoxia-inducible Factors HIF-1 and HIF-2 in Head and Neck Cancer : Relationship to Tumor Biology and Treatment Outcome in Surgically Resected Patients

Hypoxia within head and neck squamous cell carcinoma (HNSCC) predicts a poor response to radiotherapy and poor prognosis. Hypoxiainducible factor (HIF)-1 and HIF-2 are nuclear transcription factors that regulate the cellular response to hypoxia and are important for solid tumor growth and survival. Overexpression of HIF-1 and HIF-2 was demonstrated in three HNSCC cell lines under hypoxia and tumor tissue versus normal tissue (n 20, HIF-1 , P 0.023; HIF-2 , P 0.013). On immunostaining, HIF-1 and HIF-2 expression were localized to tumor nuclei; HIF-2 expression was also seen in tumor-associated macrophages. Expression of HIF-1 in surgically treated patients with HNSCC (n 79) was associated with improved disease-free survival (P 0.016) and overall survival (P 0.027).

[1]  G. Semenza,et al.  HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.

[2]  J. M. Arbeit,et al.  Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth , 2000 .

[3]  S M Evans,et al.  Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia , 1999, British Journal of Cancer.

[4]  C. West,et al.  Tumor vascularity: a histological measure of angiogenesis and hypoxia. , 2001, Cancer research.

[5]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[6]  P. Ratcliffe,et al.  Targeting tumors through the HIF system , 2000, Nature Medicine.

[7]  G. Semenza,et al.  Expression of Hypoxia-inducible Factor-1 a : A Novel Predictive and Prognostic Parameter in the Radiotherapy of Oropharyngeal Cancer 1 , 2001 .

[8]  A. Harris,et al.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Carmeliet,et al.  Heterogeneous vascular dependence of tumor cell populations. , 2001, The American journal of pathology.

[10]  A. Harris,et al.  Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. , 2001, Cancer research.

[11]  G. Semenza,et al.  Human Cancers and Their Metastases in Common α Overexpression of Hypoxia-inducible Factor 1 Updated Version , 1999 .

[12]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.

[13]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[14]  G. Semenza,et al.  Expression of hypoxia‐inducible factor 1α in brain tumors , 2000 .

[15]  A. Harris,et al.  Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. , 1998, Blood.

[16]  A. Harris,et al.  Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. , 2000, Cancer research.

[17]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[18]  M. W. D. Dvm.  Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .

[19]  J F Gross,et al.  Determination of local oxygen consumption rates in tumors. , 1994, Cancer research.